The National Centre for Immunisation Research and Surveillance (NCIRS), The Children's Hospital at Westmead, Cnr Hawkesbury Rd and Hainsworth St, Westmead 2145, Australia.
Vaccine. 2013 Aug 20;31(37):3972-8. doi: 10.1016/j.vaccine.2013.06.015. Epub 2013 Jun 15.
Post-partum vaccination of new mothers is currently recommended in Australia to reduce pertussis infection in infants. Internationally, vaccination recommendations now include pregnant women in some countries. Understanding the awareness of pertussis vaccination recommendations among pregnant women, and their willingness to have the vaccine while pregnant is important for informing vaccine program implementation.
To determine awareness and intentions toward current recommendations for post-partum pertussis vaccination among Australian pregnant women, and their willingness to accept pertussis vaccine during pregnancy, should it be recommended in Australia in the future.
Quantitative self-administered survey, using a non-random stratified sampling plan based on representative proportions by age, parity and region of residence.
Pregnant women receiving antenatal care through three large, demographically diverse referral hospitals in metropolitan, urban and rural New South Wales, Australia.
The response rate was 815/939 (87%). Most women (80%) reported willingness to have the pertussis vaccine during pregnancy, should it be recommended. Thirty four per cent of women intended to receive a pertussis vaccine post-partum, 17% had received it previously, while 45% had never heard of pertussis vaccine, had not thought about it, or were undecided about having it. Compared with those who had not received a recommendation to have the vaccine post-partum, women who had received a recommendation were 7 times more likely (95% CI 4-14) to report intention to have the vaccine.
Health care provider recommendation is paramount to raising awareness of pertussis vaccination recommendations among pregnant women. Women's willingness to have the vaccine while pregnant is encouraging, and indicates the potential for high pertussis vaccine coverage among pregnant women, should it be recommended in Australia.
目前，澳大利亚建议新妈妈在产后接种疫苗，以减少婴儿百日咳感染。在国际上，一些国家现在也建议孕妇接种疫苗。了解孕妇对百日咳疫苗接种建议的认识，以及她们在怀孕期间接种疫苗的意愿，对于为疫苗接种计划的实施提供信息非常重要。
确定澳大利亚孕妇对产后百日咳疫苗接种建议的认识和意愿，以及如果未来在澳大利亚建议接种，她们是否愿意在怀孕期间接种百日咳疫苗。
使用基于年龄、生育次数和居住地区代表性比例的非随机分层抽样计划，进行定量自我管理调查。
在澳大利亚新南威尔士州大都市、城市和农村地区的三家大型、人口统计学多样化的转诊医院接受产前护理的孕妇。
应答率为 815/939（87%）。大多数女性（80%）表示，如果建议在怀孕期间接种百日咳疫苗，她们愿意接种。34%的女性打算在产后接种百日咳疫苗，17%的女性之前已经接种过，而 45%的女性从未听说过百日咳疫苗，没有考虑过或尚未决定是否接种。与未收到产后接种疫苗建议的女性相比，收到建议的女性报告说打算接种疫苗的可能性是前者的 7 倍（95%CI 4-14）。
卫生保健提供者的建议对提高孕妇对百日咳疫苗接种建议的认识至关重要。女性在怀孕期间接种疫苗的意愿令人鼓舞，表明如果在澳大利亚建议接种，孕妇接种百日咳疫苗的覆盖率可能很高。
